Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 May;53(5):691–694. doi: 10.1038/bjc.1986.114

Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies.

J Andersen, T Orntoft, H S Poulsen
PMCID: PMC2001376  PMID: 3521693

Full text

PDF
692

Images in this article

693Figure 1
on p.693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allegra J. C., Lippman M. E., Simon R., Thompson E. B., Barlock A., Green L., Huff K. K., Do H. M., Aitken S. C., Warren R. Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep. 1979 Aug;63(8):1271–1277. [PubMed] [Google Scholar]
  2. Chamness G. C., Mercer W. D., McGuire W. L. Are histochemical methods for estrogen receptor valid? J Histochem Cytochem. 1980 Aug;28(8):792–798. doi: 10.1177/28.8.7003005. [DOI] [PubMed] [Google Scholar]
  3. DeSombre E. R., Carbone P. P., Jensen E. V., McGuire W. L., Wells S. A., Jr, Wittliff J. L., Lipsett M. B. Special report. Steriod receptors in breast cancer. N Engl J Med. 1979 Nov 1;301(18):1011–1012. doi: 10.1056/NEJM197911013011826. [DOI] [PubMed] [Google Scholar]
  4. Greene G. L., Jensen E. V. Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem. 1982 Mar;16(3):353–359. doi: 10.1016/0022-4731(82)90045-0. [DOI] [PubMed] [Google Scholar]
  5. Greene G. L., Nolan C., Engler J. P., Jensen E. V. Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5115–5119. doi: 10.1073/pnas.77.9.5115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howat J. M., Harris M., Swindell R., Barnes D. M. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer. 1985 Feb;51(2):263–270. doi: 10.1038/bjc.1985.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. King W. J., DeSombre E. R., Jensen E. V., Greene G. L. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985 Jan;45(1):293–304. [PubMed] [Google Scholar]
  8. Kinne D. W., Ashikari R., Butler A., Menendez-Botet C., Rosen P. P., Schwartz M. Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer. 1981 May 15;47(10):2364–2367. doi: 10.1002/1097-0142(19810515)47:10<2364::aid-cncr2820471007>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  9. Leake R. E., Laing L., Calman K. C., Macbeth F. R., Crawford D., Smith D. C. Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability. Br J Cancer. 1981 Jan;43(1):59–66. doi: 10.1038/bjc.1981.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Maass H., Jonat W., Stolzenbach G., Trams G. The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer. Cancer. 1980 Dec 15;46(12 Suppl):2835–2837. doi: 10.1002/1097-0142(19801215)46:12+<2835::aid-cncr2820461420>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  11. O'Hara M. F., Bedrossian C. W., Johnson T. S., Barlogie B. Flow cytometry in cancer diagnosis. Prog Clin Pathol. 1984;9:135–153. [PubMed] [Google Scholar]
  12. Pertschuk L. P., Eisenberg K. B., Carter A. C., Feldman J. G. Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response. Cancer. 1985 Apr 1;55(7):1513–1518. doi: 10.1002/1097-0142(19850401)55:7<1513::aid-cncr2820550717>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  13. Poulsen H. S. Estrogen receptors in human breast cancer: comparative features of the hydroxylapatite- and dextran-coated charcoal assay. Eur J Cancer Clin Oncol. 1982 Nov;18(11):1075–1079. doi: 10.1016/0277-5379(82)90086-4. [DOI] [PubMed] [Google Scholar]
  14. Poulsen H. S., Jensen J., Hermansen C. Human breast cancer: heterogeneity of estrogen binding sites. Cancer. 1981 Oct 15;48(8):1791–1793. doi: 10.1002/1097-0142(19811015)48:8<1791::aid-cncr2820480816>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  15. Shimada A., Kimura S., Abe K., Nagasaki K., Adachi I., Yamaguchi K., Suzuki M., Nakajima T., Miller L. S. Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4803–4807. doi: 10.1073/pnas.82.14.4803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tamura H., Raam S., Smeedy A., Pappas C. A. An update on the immunohistochemical localization of estrogen receptors in mammary carcinomas utilizing polyclonal anti-receptor antibodies. Eur J Cancer Clin Oncol. 1984 Oct;20(10):1261–1277. doi: 10.1016/0277-5379(84)90256-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES